These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 29713522)

  • 1. Influence of the Linking Order of Fragments of HA2 and M2e of the influenza A Virus to Flagellin on the Properties of Recombinant Proteins.
    Stepanova LA; Kotlyarov RY; Shuklina MA; Blochina EA; Sergeeva MV; Potapchuk MV; Kovaleva AA; Ravin NV; Tsybalova LM
    Acta Naturae; 2018; 10(1):85-94. PubMed ID: 29713522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of M2e peptide with stalk HA epitopes of influenza A virus enhances protective properties of recombinant vaccine.
    Tsybalova LM; Stepanova LA; Shuklina MA; Mardanova ES; Kotlyarov RY; Potapchuk MV; Petrov SA; Blokhina EA; Ravin NV
    PLoS One; 2018; 13(8):e0201429. PubMed ID: 30138320
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flagellin-fused protein targeting M2e and HA2 induces potent humoral and T-cell responses and protects mice against various influenza viruses a subtypes.
    Stepanova LA; Mardanova ES; Shuklina MA; Blokhina EA; Kotlyarov RY; Potapchuk MV; Kovaleva AA; Vidyaeva IG; Korotkov AV; Eletskaya EI; Ravin NV; Tsybalova LM
    J Biomed Sci; 2018 Apr; 25(1):33. PubMed ID: 29631629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protection against multiple influenza A virus strains induced by candidate recombinant vaccine based on heterologous M2e peptides linked to flagellin.
    Stepanova LA; Kotlyarov RY; Kovaleva AA; Potapchuk MV; Korotkov AV; Sergeeva MV; Kasianenko MA; Kuprianov VV; Ravin NV; Tsybalova LM; Skryabin KG; Kiselev OI
    PLoS One; 2015; 10(3):e0119520. PubMed ID: 25799221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid high-yield expression of a candidate influenza vaccine based on the ectodomain of M2 protein linked to flagellin in plants using viral vectors.
    Mardanova ES; Kotlyarov RY; Kuprianov VV; Stepanova LA; Tsybalova LM; Lomonosoff GP; Ravin NV
    BMC Biotechnol; 2015 May; 15():42. PubMed ID: 26022390
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Generation and Characterization of Universal Live-Attenuated Influenza Vaccine Candidates Containing Multiple M2e Epitopes.
    Kotomina T; Isakova-Sivak I; Kim KH; Park BR; Jung YJ; Lee Y; Mezhenskaya D; Matyushenko V; Kang SM; Rudenko L
    Vaccines (Basel); 2020 Nov; 8(4):. PubMed ID: 33153089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potent immunogenicity and efficacy of a universal influenza vaccine candidate comprising a recombinant fusion protein linking influenza M2e to the TLR5 ligand flagellin.
    Huleatt JW; Nakaar V; Desai P; Huang Y; Hewitt D; Jacobs A; Tang J; McDonald W; Song L; Evans RK; Umlauf S; Tussey L; Powell TJ
    Vaccine; 2008 Jan; 26(2):201-14. PubMed ID: 18063235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Flagellin-Fused Protein Targeting M2e and HA2 Induces Innate and T-Cell Responses in Mice of Different Genetic Lines.
    Stepanova LA; Shuklina MA; Vasiliev KA; Kovaleva AA; Vidyaeva IG; Zabrodskaya YA; Korotkov AV; Tsybalova LM
    Vaccines (Basel); 2022 Dec; 10(12):. PubMed ID: 36560509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a candidate influenza vaccine based on virus-like particles displaying influenza M2e peptide into the immunodominant region of hepatitis B core antigen: Broad protective efficacy of particles carrying four copies of M2e.
    Tsybalova LM; Stepanova LA; Kuprianov VV; Blokhina EA; Potapchuk MV; Korotkov AV; Gorshkov AN; Kasyanenko MA; Ravin NV; Kiselev OI
    Vaccine; 2015 Jun; 33(29):3398-406. PubMed ID: 25976545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Live Probiotic Vaccine Prototype Based on Conserved Influenza a Virus Antigens Protect Mice against Lethal Influenza Virus Infection.
    Mezhenskaya D; Isakova-Sivak I; Gupalova T; Bormotova E; Kuleshevich E; Kramskaya T; Leontieva G; Rudenko L; Suvorov A
    Biomedicines; 2021 Oct; 9(11):. PubMed ID: 34829744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Designing a chimeric subunit vaccine for influenza virus, based on HA2, M2e and CTxB: a bioinformatics study.
    Jafari D; Malih S; Gomari MM; Safari M; Jafari R; Farajollahi MM
    BMC Mol Cell Biol; 2020 Dec; 21(1):89. PubMed ID: 33276715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein nanoparticle vaccine based on flagellin carrier fused to influenza conserved epitopes confers full protection against influenza A virus challenge.
    Deng L; Kim JR; Chang TZ; Zhang H; Mohan T; Champion JA; Wang BZ
    Virology; 2017 Sep; 509():82-89. PubMed ID: 28622575
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunogenicity of recombinant proteins including ectodomain of M2 influenza virus A].
    Stepanova LA; Kovaleva AA; Potapchuk MV; Korotkov AV; Kupriianov VV; Blokhina EA; Kotliarov RIu; Tsybalova LM
    Vopr Virusol; 2013; 58(3):21-5. PubMed ID: 24006628
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elicitation of Highly Pathogenic Avian Influenza H5N1 M2e and HA2-Specific Humoral and Cell-Mediated Immune Response in Chicken Following Immunization With Recombinant M2e-HA2 Fusion Protein.
    Kalaiyarasu S; Bhatia S; Mishra N; Senthil Kumar D; Kumar M; Sood R; Rajukumar K; Ponnusamy B; Desai D; Singh VP
    Front Vet Sci; 2020; 7():571999. PubMed ID: 33614753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plant-Produced Recombinant Influenza A Virus Candidate Vaccine Based on Flagellin Linked to Conservative Fragments of M2 Protein and Hemagglutintin.
    Blokhina EA; Mardanova ES; Stepanova LA; Tsybalova LM; Ravin NV
    Plants (Basel); 2020 Jan; 9(2):. PubMed ID: 32013187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective Immunity Against Homologous and Heterologous Influenza Virus Lethal Challenge by Immunization with New Recombinant Chimeric HA2-M2e Fusion Protein in BALB/C Mice.
    Ameghi A; Pilehvar-Soltanahmadi Y; Baradaran B; Barzegar A; Taghizadeh M; Zarghami N; Aghaiypour K
    Viral Immunol; 2016 May; 29(4):228-34. PubMed ID: 27058011
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generation of New M2e-HA2 Fusion Chimeric Peptide to Development of a Recombinant Fusion Protein Vaccine.
    Ameghi A; Baradaran B; Aghaiypour K; Barzegar A; Pilehvar-Soltanahmadi Y; Moghadampour M; Taghizadeh M; Zarghami N
    Adv Pharm Bull; 2015 Dec; 5(Suppl 1):673-81. PubMed ID: 26793615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An amphiphilic invertible polymer as a delivery vehicle for a M2e-HA2-HA1 peptide vaccine against an Influenza A virus in pigs.
    Singh G; Zholobko O; Pillatzki A; Webb B; Nelson E; Voronov A; Ramamoorthy S
    Vaccine; 2019 Jul; 37(31):4291-4301. PubMed ID: 31235376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tandem repeats of the extracellular domain of Matrix 2 influenza protein exposed in Brucella lumazine synthase decameric carrier molecule induce protection in mice.
    Alvarez P; Zylberman V; Ghersi G; Boado L; Palacios C; Goldbaum F; Mattion N
    Vaccine; 2013 Jan; 31(5):806-12. PubMed ID: 23246552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly conserved M2e and hemagglutinin epitope-based recombinant proteins induce protection against influenza virus infection.
    Guo Y; He L; Song N; Li P; Sun S; Zhao G; Tai W; Jiang S; Du L; Zhou Y
    Microbes Infect; 2017 Dec; 19(12):641-647. PubMed ID: 28903071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.